热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　远大医药（00512）早盘高开逾6%，截至发稿，股价上涨3.74%，现报6.11港元，成交额1087.24万港元。

　　4月22日，远大医药发布公告，集团开发的用于治疗过敏性鼻炎的丙酸氟替卡松鼻喷雾剂近日获得中华人民共和国国家药品监督管理局（药监局）颁发的药品注册证书，该产品为中国首仿上市产品，且已被纳入国家医保目录和国家基本用药目录，此次，该产品的获批上市是集团在呼吸及危重症领域的又一次重大研发进展。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.